Eaton Vance Worldwide Health Sciences Fund Buys Johnson & Johnson, CSL, Baxter International Inc, Sells Roche Holding AG, HCA Healthcare Inc, Shire PLC

• New Purchases: CSL, BAX, ABT, IPN, COLO B, AMED, MDSO, AVXS, AGIO, NBIX,
• Added Positions: JNJ, ANTM,
• Reduced Positions: ROG, SHP, CELG, ZTS, LLY, AET, UCB, PFE, PCRX, AZN,
• Sold Out: HCA, CTEC, HOLX, COO, 4536,

For the details of Eaton Vance Worldwide Health Sciences Fund's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Eaton+Vance+Worldwide+Health+Sciences+Fund

1. Johnson & Johnson (JNJ) - 496,664 shares, 6.29% of the total portfolio. Shares added by 43.03%
2. UnitedHealth Group Inc (UNH) - 281,146 shares, 6.2% of the total portfolio.
3. AbbVie Inc (ABBV) - 384,088 shares, 4.33% of the total portfolio.
4. Pfizer Inc (PFE) - 1,135,385 shares, 4.02% of the total portfolio. Shares reduced by 14.5%
5. Gilead Sciences Inc (GILD) - 505,918 shares, 3.88% of the total portfolio.

Eaton Vance Worldwide Health Sciences Fund initiated holding in CSL Ltd. The purchase prices were between $139.42 and $164.66, with an estimated average price of $145.41. The stock is now traded at around $168.95. The impact to a portfolio due to this purchase was 1.82%. The holding were 147,984 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund initiated holding in Baxter International Inc. The purchase prices were between $62.56 and $72.26, with an estimated average price of $66.97. The stock is now traded at around $69.94. The impact to a portfolio due to this purchase was 1.78%. The holding were 268,893 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund initiated holding in Abbott Laboratories. The purchase prices were between $54.64 and $63.42, with an estimated average price of $58.35. The stock is now traded at around $58.23. The impact to a portfolio due to this purchase was 1.18%. The holding were 201,406 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund initiated holding in Ipsen SA. The purchase prices were between $98.15 and $123.85, with an estimated average price of $108.04. The stock is now traded at around $134.50. The impact to a portfolio due to this purchase was 0.7%. The holding were 49,235 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund initiated holding in Coloplast A/S. The purchase prices were between $483.3 and $534.4, with an estimated average price of $505.69. The stock is now traded at around $524.00. The impact to a portfolio due to this purchase was 0.64%. The holding were 77,942 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund initiated holding in Amedisys Inc. The purchase prices were between $50.51 and $59.43, with an estimated average price of $54.43. The stock is now traded at around $65.69. The impact to a portfolio due to this purchase was 0.57%. The holding were 98,734 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund added to a holding in Johnson & Johnson by 43.03%. The purchase prices were between $126.36 and $148.14, with an estimated average price of $138.89. The stock is now traded at around $125.38. The impact to a portfolio due to this purchase was 1.89%. The holding were 496,664 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund added to a holding in Anthem Inc by 66.94%. The purchase prices were between $222.71 and $258.19, with an estimated average price of $234.66. The stock is now traded at around $234.25. The impact to a portfolio due to this purchase was 0.78%. The holding were 85,211 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund sold out a holding in HCA Healthcare Inc. The sale prices were between $80.14 and $102.24, with an estimated average price of $92.05.

Eaton Vance Worldwide Health Sciences Fund sold out a holding in ConvaTec Group PLC. The sale prices were between $2.56 and $2.84, with an estimated average price of $2.69.

Eaton Vance Worldwide Health Sciences Fund sold out a holding in Hologic Inc. The sale prices were between $37.75 and $44.42, with an estimated average price of $42.

Eaton Vance Worldwide Health Sciences Fund sold out a holding in The Cooper Companies Inc. The sale prices were between $217.88 and $245.58, with an estimated average price of $231.12.

Eaton Vance Worldwide Health Sciences Fund sold out a holding in Santen Pharmaceutical Co Ltd. The sale prices were between $15.01 and $15.75, with an estimated average price of $15.31.

Eaton Vance Worldwide Health Sciences Fund reduced to a holding in Roche Holding AG by 50.49%. The sale prices were between $215.95 and $252.2, with an estimated average price of $236.31. The stock is now traded at around $220.85. The impact to a portfolio due to this sale was -2.35%. Eaton Vance Worldwide Health Sciences Fund still held 99,147 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund reduced to a holding in Shire PLC by 38.66%. The sale prices were between $29.92 and $39.2, with an estimated average price of $35.06. The stock is now traded at around $38.66. The impact to a portfolio due to this sale was -1.23%. Eaton Vance Worldwide Health Sciences Fund still held 430,145 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund reduced to a holding in Celgene Corp by 28.95%. The sale prices were between $87.12 and $109.41, with an estimated average price of $101.76. The stock is now traded at around $86.96. The impact to a portfolio due to this sale was -1.04%. Eaton Vance Worldwide Health Sciences Fund still held 274,651 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund reduced to a holding in Zoetis Inc by 32.03%. The sale prices were between $70.85 and $83.3, with an estimated average price of $75.02. The stock is now traded at around $83.07. The impact to a portfolio due to this sale was -1.02%. Eaton Vance Worldwide Health Sciences Fund still held 323,897 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund reduced to a holding in Eli Lilly and Co by 23.06%. The sale prices were between $74.21 and $87.89, with an estimated average price of $83.29. The stock is now traded at around $79.12. The impact to a portfolio due to this sale was -1%. Eaton Vance Worldwide Health Sciences Fund still held 430,672 shares as of 2018-02-28.

Eaton Vance Worldwide Health Sciences Fund reduced to a holding in Aetna Inc by 27.69%. The sale prices were between $175.06 and $193.74, with an estimated average price of $181.78. The stock is now traded at around $178.91. The impact to a portfolio due to this sale was -0.71%. Eaton Vance Worldwide Health Sciences Fund still held 111,910 shares as of 2018-02-28.